Order Article Reprints

Alharbi WS, Hareeri RH, Bazuhair M, Alfaleh MA, Alhakamy NA, Fahmy UA, Alamoudi AA, Badr-Eldin SM, Ahmed OA, AlGhamdi SA, et al. Spanlastics as a Potential Platform for Enhancing the Brain Delivery of Flibanserin: In Vitro Response-Surface Optimization and In Vivo Pharmacokinetics Assessment. Pharmaceutics. 2022; 14(12):2627. https://doi.org/10.3390/pharmaceutics14122627

Alharbi, Waleed S., Rawan H. Hareeri, Mohammed Bazuhair, Mohamed A. Alfaleh, Nabil A. Alhakamy, Usama A. Fahmy, Abdullah A. Alamoudi, Shaimaa M. Badr-Eldin, Osama A. Ahmed, Shareefa A. AlGhamdi, and et al. 2022. "Spanlastics as a Potential Platform for Enhancing the Brain Delivery of Flibanserin: In Vitro Response-Surface Optimization and In Vivo Pharmacokinetics Assessment" Pharmaceutics 14, no. 12: 2627. https://doi.org/10.3390/pharmaceutics14122627

Alharbi, W. S., Hareeri, R. H., Bazuhair, M., Alfaleh, M. A., Alhakamy, N. A., Fahmy, U. A., Alamoudi, A. A., Badr-Eldin, S. M., Ahmed, O. A., AlGhamdi, S. A., & Naguib, M. J. (2022). Spanlastics as a Potential Platform for Enhancing the Brain Delivery of Flibanserin: In Vitro Response-Surface Optimization and In Vivo Pharmacokinetics Assessment. Pharmaceutics, 14(12), 2627. https://doi.org/10.3390/pharmaceutics14122627